A phase I study of the trinuclear platinum compound, BBR 3464, in combination with protracted venous infusional 5-fluorouracil in patients with advanced cancer Charlie GourleyJames CassidyDuncan Jodrell Original Article 07 November 2003 Pages: 95 - 101
Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects Ann E. BoltonBin PengMichael Seiberling Original Article 07 November 2003 Pages: 102 - 106
Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase Michael C. NivensTakita FelderH. Trent Spencer Original Article 07 November 2003 Pages: 107 - 115
Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-d-glucose in tumor cells treated under hypoxic vs aerobic conditions Johnathan C. MaherAwtar KrishanTheodore J. Lampidis Original Article 07 November 2003 Pages: 116 - 122
The cardiovascular safety of high-dose intravenous granisetron in cancer patients receiving highly emetogenic chemotherapy James CarmichaelAdrian L. Harris Original Article 22 November 2003 Pages: 123 - 128
Phase II study of the combination of vinorelbine and cisplatin in advanced non-small-cell lung cancer Kiyoshi MoriYukari KamiyamaKeigo Tominaga Original Article 07 November 2003 Pages: 129 - 132
LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing mice Kristan A. KeyesLarry MannBeverly A. Teicher Original Article 31 October 2003 Pages: 133 - 140
Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats Shri N. GiriMohammed Ali Al-BayatiSolomon B. Margolin Original Article 15 October 2003 Pages: 141 - 150
Thymidine phosphorylase expression is preserved after radiotherapy in patients with cervical squamous cell carcinoma Hiroyoshi OguriNagamasa MaedaTakao Fukaya Original Article 12 November 2003 Pages: 151 - 154
Differences in the longevity of topo IIα and topo IIβ drug-stabilized cleavable complexes and the relationship to drug sensitivity Fiona ErringtonElaine WillmoreCaroline A. Austin Original Article 23 September 2003 Pages: 155 - 162
Antitumoral properties of two new vanadyl(IV) complexes in osteoblasts in culture: role of apoptosis and oxidative stress María S. MolinuevoDaniel A. BarrioSusana B. Etcheverry Original Article 09 October 2003 Pages: 163 - 172
The influence of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) on the brain penetration of paclitaxel in mice E. Marleen KemperCindy CleypoolOlaf van Tellingen Original Article 07 November 2003 Pages: 173 - 178
P-glycoprotein expression does not change the apoptotic pathway induced by curcumin in HL-60 cells Anna Bielak-ŻmijewskaKatarzyna PiwockaEwa Sikora Original Article 03 October 2003 Pages: 179 - 185
In vitro effects of trastuzumab and vinorelbine in trastuzumab-resistant breast cancer cells Rita NahtaFrancisco J. Esteva Short Communication 07 November 2003 Pages: 186 - 190